Recent Developments in Immuno-oncology: Biomarkers, Pan-tumor Studies, Novel Treatment Combinations, and the Management of Adverse Events

Track 2: Biomarkers for Immunotherapies Across Tumor Type




Thursday, May 21, 2020

8:00 AM – 9:00 AM ET

Please note this Virtual program is at 8:00AM Eastern, 7:00AM Central, 6:00AM Mountain, and 5:00AM Pacific.

Jeffrey Weber, MD
Deputy Director, Laura & Isaac Perlmutter Comprehensive Cancer Center
NYU Langone Health
New York, NY

Learning Objectives

After completing the CME activity, learners should be better able to:

  • Review the clinical utility of currently identified immune-related biomarkers and the benefits and limitations of different immune biomarker testing methodologies
  • Incorporate immune-related biomarker testing to identify patients most likely to benefit from cancer immunotherapies administered alone or in combination
  • Describe immune-related biomarker-driven pan-tumor studies, their designs, and the implications of their results for patient management

Target Audience

This initiative is designed to meet the educational needs of oncologists, oncology pharmacists, oncology nurses, and other healthcare professionals and teams involved in the management of patients with cancer who are treated or eligible for treatment with immunotherapy.

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Med Learning Group designates this live activity for a maximum of 1.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.


This program would be beneficial for nurses involved in the care of pa­tients with cancer who are treated or eligible for treatment with immunotherapy.

1.0 ANCC Contact Hour(s)

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.


In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.


Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.


Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at:




Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.